Biodexa Pharmaceuticals (BDRX) Stock Chart & Stock Price History → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free BDRX Stock Alerts $1.30 +0.58 (+80.56%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Biodexa Pharmaceuticals Stock Price Performance5 Day Performance+60.87%1 Month Performance-19.75%3 Month Performance-31.94%6 Month Performance-66.06%Year-To-Date Performance-51.49%1 Year Performance-92.82% Receive BDRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him BDRX Stock Chart for Sunday, April, 28, 2024 BDRX Chart by TradingView Biodexa Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$0.72$1.30+80.56%$1.74$1.1470.61 million shs$1.68 million04/25/2024$0.74$0.72-2.73%$0.74$0.67138,398 shs$929,000.0004/24/2024$0.81$0.74-8.40%$0.80$0.71149,121 shs$955,000.0004/23/2024$0.77$0.81+5.63%$0.83$0.7777,430 shs$1.04 million04/22/2024$0.75$0.77+1.73%$0.79$0.75101,085 shs$985,000.0004/19/2024$0.82$0.75-8.29%$0.83$0.75150,100 shs$970,000.00 Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.87$0.82-5.64%$0.84$0.8096,354 shs$1.06 million04/17/2024$0.86$0.87+0.99%$0.87$0.8227,587 shs$1.12 million04/16/2024$0.83$0.86+3.28%$0.87$0.81118,215 shs$1.11 million04/15/2024$0.92$0.83-9.15%$0.93$0.82129,297 shs$1.08 million04/12/2024$0.96$0.92-4.81%$0.99$0.91123,649 shs$1.18 million04/11/2024$0.98$0.96-1.86%$1.00$0.9571,425 shs$1.24 million04/10/2024$0.99$0.98-1.01%$1.00$0.95171,139 shs$1.26 million04/09/2024$1.03$0.99-3.88%$1.03$0.94113,413 shs$1.28 million04/08/2024$1.07$1.03-3.74%$1.06$1.00146,622 shs$1.33 million04/05/2024$1.16$1.07-7.76%$1.16$1.07202,289 shs$1.38 million04/04/2024$1.10$1.16+5.45%$1.20$1.11270,577 shs$1.50 million04/03/2024$1.36$1.10-19.12%$1.32$1.10785,519 shs$1.42 million04/02/2024$1.46$1.36-6.85%$1.44$1.27751,168 shs$1.75 million04/01/2024$1.62$1.46-9.88%$1.55$1.202.57 million shs$1.88 million03/29/2024$1.62$1.62$2.00$1.3587.90 million shs$2.09 million03/28/2024$0.86$1.62+88.59%$2.00$1.3588.16 million shs$2.09 million03/27/2024$0.80$0.86+7.20%$0.86$0.8084,856 shs$1.11 million03/26/2024$0.98$0.80-18.23%$0.97$0.72582,505 shs$1.03 million03/25/2024$1.05$0.98-6.67%$1.06$0.88122,562 shs$1.26 million03/22/2024$1.05$1.05$1.06$1.0449,030 shs$1.35 million03/21/2024$1.05$1.05$1.07$1.0351,312 shs$1.35 million03/20/2024$1.03$1.05+1.94%$1.05$1.0057,216 shs$1.35 million03/19/2024$1.14$1.03-9.65%$1.05$1.00243,855 shs$1.33 million03/18/2024$1.17$1.14-2.56%$1.22$1.13169,264 shs$1.47 million03/15/2024$1.13$1.17+3.54%$1.19$1.1494,263 shs$1.51 million03/14/2024$1.27$1.13-11.02%$1.27$1.11229,441 shs$1.45 million03/13/2024$1.27$1.27$1.29$1.2474,567 shs$1.63 million03/12/2024$1.31$1.27-3.05%$1.30$1.2591,069 shs$1.64 million03/11/2024$1.30$1.31+0.77%$1.33$1.2770,916 shs$1.69 million03/08/2024$1.31$1.30-0.76%$1.33$1.26133,047 shs$1.68 million03/07/2024$1.29$1.31+1.55%$1.32$1.27107,300 shs$1.69 million03/06/2024$1.28$1.29+0.78%$1.34$1.25218,538 shs$1.66 million03/05/2024$1.30$1.28-1.54%$1.33$1.28133,417 shs$1.65 million03/04/2024$1.36$1.30-4.41%$1.37$1.30189,121 shs$1.67 millionClaim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now03/01/2024$1.27$1.36+7.09%$1.43$1.29547,856 shs$1.75 million02/29/2024$1.32$1.27-3.79%$1.35$1.26142,334 shs$1.64 million02/28/2024$1.38$1.32-4.35%$1.35$1.24286,380 shs$1.70 million02/27/2024$1.39$1.38-0.72%$1.39$1.33121,665 shs$1.78 million02/26/2024$1.49$1.39-6.71%$1.45$1.31317,409 shs$1.79 million02/23/2024$1.54$1.49-3.25%$1.73$1.314.11 million shs$1.92 million02/22/2024$1.53$1.54+0.65%$1.57$1.51149,147 shs$1.99 million02/21/2024$1.62$1.53-5.56%$1.62$1.53222,641 shs$1.97 million02/20/2024$1.55$1.62+4.52%$1.64$1.50268,687 shs$2.09 million02/19/2024$1.55$1.55$1.60$1.51278,800 shs$2 million02/16/2024$1.59$1.55-2.52%$1.60$1.51257,583 shs$2 million02/15/2024$1.72$1.59-7.56%$1.67$1.55441,010 shs$2.05 million02/14/2024$1.80$1.72-4.44%$1.82$1.62959,183 shs$2.21 million02/13/2024$1.45$1.80+24.14%$2.11$1.5811.86 million shs$2.32 million02/12/2024$1.31$1.45+10.69%$1.54$1.32599,240 shs$1.87 million02/09/2024$1.30$1.31+0.77%$1.46$1.28479,808 shs$1.69 million02/08/2024$1.35$1.30-3.70%$1.49$1.211.41 million shs$1.68 million02/07/2024$1.53$1.35-11.77%$2.00$1.329.30 million shs$1.74 million02/06/2024$1.32$1.53+15.92%$1.81$1.31628,661 shs$1.97 million02/05/2024$1.42$1.32-7.04%$1.51$1.2341,840 shs$1.70 million02/02/2024$1.43$1.42-0.70%$1.55$1.4034,276 shs$1.83 million02/01/2024$1.61$1.43-11.18%$1.75$1.4194,254 shs$1.85 million01/31/2024$1.67$1.61-3.59%$1.76$1.6062,990 shs$2.08 million01/30/2024$1.89$1.67-11.64%$1.95$1.6691,398 shs$2.15 million01/29/2024$1.91$1.89-1.05%$1.98$1.888,644 shs$2.44 million Related Companies: 180 Life Sciences Stock Chart SciSparc Stock Chart Evelo Biosciences Stock Chart Evofem Biosciences Stock Chart PainReform Stock Chart China SXT Pharmaceuticals Stock Chart NeuBase Therapeutics Stock Chart Bellerophon Therapeutics Stock Chart Aditxt Stock Chart GRI Bio Stock Chart Receive BDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BDRX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.